Producing a Key Protein for Antiphospholipid Syndrome in Bacteria
Author Information
Author(s): Ioannou Yiannis, Giles Ian, Lambrianides Anastasia, Richardson Chris, Pearl Laurence H, Latchman David S, Isenberg David A, Rahman Anisur
Primary Institution: University College London
Hypothesis
We hypothesise that the challenges in expressing domain I of human beta2 glycoprotein I in E. coli are related to codon bias, potential toxicity, and disulphide bond formation difficulties.
Conclusion
Efficient, soluble expression of the eukaryotic protein domain I of beta2 glycoprotein I in E. coli is achievable, which may aid future antigenic studies and therapeutic applications.
Supporting Evidence
- The study achieved yields of 750 μg/L of the target protein.
- Recombinant DI was shown to bind human monoclonal antiphospholipid antibodies.
- The expression system allowed for the production of conformationally correct DI.
Takeaway
Scientists figured out how to make a special protein in bacteria that can help understand a disease that causes blood clots and miscarriages.
Methodology
The study used a synthetic gene designed for E. coli expression, followed by recursive PCR and tight regulation of expression using the T7lac promoter.
Limitations
The study does not address potential post-translational modifications that may be necessary for the protein's biological activity.
Participant Demographics
The study involved 21 patients with antiphospholipid syndrome, 14 patients with systemic lupus erythematosus, and 9 healthy controls.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website